Published on
October 15, 2025
- 07:27 GMT
Alanis Therapeutics Announces Collaboration with Blood Cancer United’s Beat AML to Advance Therapeutic for MDS/AML
Collaboration to assess elevated Notch 1/jagged-1 oncogenic signaling in different AML molecular subtypes from the Beat AML Master Trial SAN DIEGO, CA, UNITED STATES, October 15, 2025 /EINPresswire.com/ -- Alanis Therapeutics Inc. (“ATI”), together with …
Distribution channels:
Healthcare & Pharmaceuticals Industry
...
